I joined Novartis Institute for BioMedical Science in 2021 as a principal scientist. Prior to that, I was a postdoc at MIT. During my postdoc, I did research on reaction development using the main group element. I completed my PhD at Scripps Research in 2022, working on the total synthesis of natural products.